Trend

Aclaris Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -58.56% during the next 3 months and, with 90% probability hold a price between $0.39 and $1.43 at the end of this period.

Signals

There are few to none technical positive signals at the moment. Aclaris Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.15 and $3.57. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday July 03, 2019, which indicates further falls until a new bottom pivot has been found. Aclaris Therapeutics gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

RSI14 is 43 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Risk